News & Press Release
NEWS
Presentation of Saturn at TVT 2021 – July 2021
Our technology has been presented at 2021 TVT to be held on July 20-22 in Miami, FL. Specifically, Dr. Torsten Vahl, MD, spoke about "Circumferential Mitral Leaflet Capture and Annular Resizing – InnovHeart".
Presentation of Saturn at EuroPCR 2021 – May 2021
Our Saturn Device was presented at 2021 EuroPCR held on May 18-20. Dr. Paolo Denti, MD, presented the earliest clinical results of the TransApical implant, while Dr. Torsten Vahl, MD, illustrated the advancements in the TransSeptal technology. Full videos available...
Presentation of Saturn Device at TCT 2019 – September 2019
Saturn Device was presented at 2019 TCT held on September 25–29 in San Francisco – California. See the presentation here.
Presentation of Saturn Device at Mitral Valve Meeting 2018 – February 2018
Saturn Device was presented at 2018 Mitral Valve Meeting held on February 25–27 in Zurich – Switzerland, during Live cases (surgical and interventional mitral valve repair), Breaking news, imaging and trial data snapshots on mitral valve repair and replacement. See...
Saturn Device on Journal of the American College of Cardiology – May 2017
Saturn Device mentioned on Journal of the American College of Cardiology, Volume 69, Issue 17, May 2017. Read the full article here.
PRESS RELEASE
InnovHeart appoints David Wilson as Chief Executive Officer
Industry Leader to Guide Company and the Saturn TMVR Programin its Next Phase of Growth InnovHeart s.r.l. announced today the appointment of David James Wilson, an experienced healthcare and medical device executive as Chief Executive Officer of the company and...
InnovHeart raises $55 million in Series C financing to further develop the Trans-septal Saturn Transcatheter Mitral Valve Replacement System
InnovHeart and Grand Pharmaceutical Group Enter Into an Exclusive License Agreement to Develop and Commercialize the Saturn TMVR Device in Greater China Milan, January 27, 2022 - InnovHeart s.r.l., a developer of novel Transcatheter Mitral Valve Replacement...
Azin Parhizgar, Ph.D. Joins InnovHeart as Independent Member of the Board of Directors
InnovHeart s.r.l., a developer of novel Transcatheter Mitral Valve Replacement (TMVR) systems for the treatment of Mitral Regurgitation, announced today the appointment of successful serial entrepreneur and medical device executive Dr. Azin Parhizgar, Ph.D. as an...
InnovHeart Reports Successful First-in- Human Implantation of its Saturn Transcatheter Mitral Valve with Excellent 30-day Follow-up
InnovHeart s.r.l., a developer of novel Transcatheter Mitral Valve Replacement (TMVR) systems for the treatment of Mitral Regurgitation (MR), announced today the successful Firstin-Human implantation of its proprietary Saturn Transcatheter Mitral Valve along with...
Transcatheter Mitral Valve Replacement Company InnovHeart Closes Series B Financing of €20 Million
InnovHeart s.r.l., a developer of novel Transcatheter Mitral Valve Replacement (TMVR) systems for the treatment of mitral valve disease, announced today the closing of a €20 million round of equity financing. Founded in 2015 by Giovanni Righini, a 30-year veteran of...